Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR).

Ciro FranzeseVeronica VernierMarco BadalamentiRaffaella LucchiniSara StefaniniAnna BertoliniMaryia IlievaLuciana Di CristinaBeatrice MariniDavide FranceschiniTiziana ComitoRuggero SpotoLuca DominiciCarmela GaldieriPietro MancosuStefano TomatisMarta Scorsetti

Published in: Cancers (2024)

SABR offers a valuable treatment option for oligometastatic RCC, demonstrating significant potential for achieving long-term disease control and delaying the need for systemic therapy.

Keyphrases

radiation therapy
renal cell carcinoma
early stage
stem cells
squamous cell carcinoma
mesenchymal stem cells
bone marrow
newly diagnosed
cell therapy
chemotherapy induced